Dr Luc Beaulieu

Luc Beaulieu received his PhD from Université Laval in 1996. After a postdoctoral fellowship in Berkeley, California, he worked as a research scientist at the Indiana University Cyclotron Facility in Bloomington. In 2000, he took the leadership of the medical physics research group at Quebec City University Hospital. Under his leadership, a formal graduate medical physics teaching curriculum was set-up and became CAMPEP accredited in 2011.

In addition to being a researcher at the Centre de recherche du CHU de Québec – Université Laval, Dr. Beaulieu is a full professor at Université Laval, Director of the CAMPEP graduate program (since 2011) and also Director of University Laval Cancer Research Centre (since 2012). From 2010 to 2016, he served on the Board of the Canadian Organization of Medical Physicists as President Elect, President and Past President. He is a member of the AAPM Brachytherapy Subcommittee as well as two associated Working Groups (Robotics and Clinical Applications), is the Chair of TG317 on tracking technology for brachytherapy, a member of the ESTRO In Vivo dosimetry working group, was the Chair of TG-186 and until recently led the AAPM/ESTRO/ABG Working Group on Model-Based Dose Calculations in Brachytherapy. He received research grants from all of the Canadian major funding agencies (CIHR, NSERC, NCIC, CCSRI) and NIH (R01 and SBIR). For the past 15 years, Dr. Beaulieu has worked collaboratively with a number of industrial partners for the design, building and validation of biomedical algorithms and devices. Since November 2015, he is the holder of an NSERC Industrial Research Chair related to biomedical technology for brachytherapy. He has served on grants panels for most of the agencies listed previously and reviews on an ad hoc basis grants for programs in France and Belgium.

He has mentored over 70 graduate students and postdoctoral fellows and more then 80 undergraduate student research projects, published 217 peer-reviewed manuscripts (close to 7000 citations) and 465 refereed abstracts (all poster and oral presentations) at national and international meetings. He is a recognized expert on topics related to scintillation dosimetry and brachytherapy.

Luc is the father of two wonderful young adults and a 5-year-old child. He loves skiing, skating, cycling and reading. According to his wife, he also cannot resist new high-tech gadgets.


Dr Michael Folkert

Dr. Michael R. Folkert is an Assistant Professor and Medical Residency Director in the Department of Radiation Oncology at the UT Southwestern Medical Center (UTSW) in Dallas, TX, USA. At UTSW, he serves as the Co-Director of the Brachytherapy Program and Director of the Intraoperative Radiation Therapy Program, and co-leads their multi-disciplinary Sarcoma and Gastrointestinal Malignancy programs.

He originally trained as a medical physicist at the Massachusetts Institute of Technology and Massachusetts General Hospital with a PhD in Radiological Sciences, but then transitioned to clinical medicine, training at Harvard Medical School and then Memorial Sloan Kettering Cancer Center with an emphasis on Brachytherapy. His clinical research focuses on novel brachytherapy applicators for all body sites, toxicity assessment and reduction techniques in brachytherapy and stereotactic body radiation therapy, and complex multiparametric image analysis for cancer outcomes prediction. Additionally, he has a professional interest in brachytherapy and procedural education for residents and practicing physicians. He has served as PI on Phase I and II clinical trials, has published over 40 peer-reviewed papers and authored 9 book chapters, and has received grant funding from industry, the American Cancer Society, NIH, and the Cancer Prevention and Research Institute of Texas.

Prof. Nikolaos Zamboglou

Born in Limassol in 1949. In 1996 finished school. After having received a DAAD (Deutscher Akademischer Austausch Dienst) scholarship in Physics studies at the Technical University of Aachen. In 1974 degree Dipl. Phys. (MSc in Physics).

Between 1974 – 1977 graduated with thesis and degree Dr. rer. nat. (PhD in Physics) at the Department of Nuclear Research KFA Julich at the University of Dusseldorf after being granted a KFA scholarship.

1979 – 1985: Medical studies at the Medical School of the University of Essen

1985: Degree MD. During the same period of time research fellow and head of the department of Fluoroscopy at the Institute of Radiobiology and Medical Physics at the University of Essen

1985 – 1986: Resident in Radiation – Ocology at the Alfried Krupp Hospital in Essen

1986 – 1989: Completion of residency program in Radiation – Oncology at the University Hospital Dusseldorf, Germany

1987: Doctoral degree Dr. med (PhD in Medicine) from the Medical School of the University of Essen

1989: Associated Professor in Radiation Oncology (Priv. Doz.)

1990 – 1992: Senior attending physician at the Department of Radiation Oncology of the University of Dusseldorf

1992: Head of Department and Professor of Radiation – Oncology at the Department of Radiotherapy of the Offenbach Hospital, teaching hospital of the Johann Wolfgang Goethe University of Frankfurt

1993: Adjunct Research professor at the National Technical University of Athens at the Institute of Communication and Computer Systems

2001 – 2007: Member of the Board of Directors of the German Society of Radiation Oncology (DEGRO).

2003 – 2005: President of the German Society of Radiation Oncology (DEGRO).

  •  Contribution of 157 publication in renowned international scientific journals with approximately 1200 citations. The academic work also included the editing and authorship of 7 books as well as 23 book-chapters in the field of oncology
  • During the 70’s, as physicist at the KFA Julich (Centre for Nuclear Research Julich) and the Institute of Medical Physics and Radiation of the University of Essen, the main research area was on the topics of biological dosimetry and Fluoroscopy. In the 80’s, at the University of Dusseldorf, the activities were based on the field of simultaneous radio-chemotherapy and implementation of the results to the translational research
  • As Head of the Department of Radiation Oncology at the Offenbach Hospital in 1992, clinical as well as technical research in the field of interventional radiotherapy – brachytherapy

Clinical Applications 

Over the past years, extension of the spectrum of treatment indications for interventional radiotherapy. The advantages of image guidance and individualised dose shaping, enabled the effective application of interstitial brachytherapy for the treatment of prostate and breast cancer, sarcomas as well as brain tumour and solid tumour recurrances.

Especially in the curative treatment of prostate cancer, brachytherapy yields the same treatment results compared to radical surgery. However, the percentage of treatment related urinary incontinence is insignificant and the proportion of patients with preserved erectile function exceeds 80%.

Advanced interventional radiotherapeutical treatment to more than 15,000 patients, through progresses in the optimisation of dose distribution and advanced methods of virtual treatment simulation. Education of physicians from more than 120 institutions, including 10 centres from Greece, in brachytherapy methods.


1991 Hanns Langendorff Price of the Medical Society for Radiation Protection, Germany

1998 Price of the German Society for Senology

2001 Richard-Mertens Price for Innovative Research

2002 Price of the German Society for Surgery

2003 Price of the German Society for Medical Technology

2009 Corresponding Member of the Academy of Athens

2009 Honorary Member of the Medical Society of Limssol, Cyprus

2010 “Strebel Medal for Brachytherapy” of the German, Austrian and Swiss Societies for Radiation Oncology

2011 Honorary Member of the Austrian Society of Radiation Oncology

2014 Alfred Breit price of the German Society for Radiation Oncology

2017 Honorary Doctorate awarded by Cyprus University of Technology